000 | 01659 a2200409 4500 | ||
---|---|---|---|
005 | 20250514182827.0 | ||
264 | 0 | _c20040601 | |
008 | 200406s 0 0 jpn d | ||
022 | _a0047-1852 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSohen, Satoshi | |
245 | 0 | 0 |
_a[Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases]. _h[electronic resource] |
260 |
_bNihon rinsho. Japanese journal of clinical medicine _cFeb 2004 |
||
300 |
_a673-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
650 | 0 | 4 |
_aBone Resorption _xdiagnosis |
650 | 0 | 4 |
_aCollagen Diseases _xcomplications |
650 | 0 | 4 |
_aCytokines _xphysiology |
650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
650 | 0 | 4 |
_aGlycoproteins _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation Mediators _xphysiology |
650 | 0 | 4 | _aInterleukin 1 Receptor Antagonist Protein |
650 | 0 | 4 | _aOsteoprotegerin |
650 | 0 | 4 |
_aPrednisolone _xadverse effects |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xphysiology |
650 | 0 | 4 |
_aReceptors, Interleukin-1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, Interleukin-6 _xantagonists & inhibitors |
650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 |
_aSialoglycoproteins _xtherapeutic use |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _ximmunology |
773 | 0 |
_tNihon rinsho. Japanese journal of clinical medicine _gvol. 62 Suppl 2 _gp. 673-6 |
|
999 |
_c14752653 _d14752653 |